Akihiro Muto
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Depleting HIF‑1α attenuates the progression of osteosarcoma, but tumorigenicity is sustained through HIF‑independent pathways.
Journal: Oncology reports
Published: September 10, 2025
MEK inhibition preferentially suppresses anchorage-independent growth in osteosarcoma cells and decreases tumors in vivo.
Journal: Journal of orthopaedic research : official publication of the Orthopaedic Research Society
Published: February 18, 2021
Activation of ventral tegmental area dopaminergic neurons reverses pathological allodynia resulting from nerve injury or bone cancer.
Journal: Molecular pain
Published: January 24, 2018
Simvastatin-Induced Apoptosis in Osteosarcoma Cells: A Key Role of RhoA-AMPK/p38 MAPK Signaling in Antitumor Activity.
Journal: Molecular cancer therapeutics
Published: July 28, 2016
Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells.
Journal: Cancer science
Published: December 09, 2014
IGF2 preserves osteosarcoma cell survival by creating an autophagic state of dormancy that protects cells against chemotherapeutic stress.
Journal: Cancer research
Published: October 03, 2014
Up-regulation of Imp3 confers in vivo tumorigenicity on murine osteosarcoma cells.
Journal: PloS one
Published: August 28, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026